Mark Slifstein

According to our database, Mark Slifstein authored at least 12 papers between 2001 and 2012.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2012

Extended characterisation of the serotonin 2A (5-HT_2A) receptor-selective PET radiotracer ¹¹C-MDL100907 in humans: Quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

Peter S. Talbot, Mark Slifstein, Dah-Ren Hwang, Yiyun Huang, Erica Scher, Anissa Abi-Dargham, Marc Laruelle

NeuroImage, 2012

2010

Dopamine transmission in comorbid schizophrenia and substance dependence.

Nina Urban, Mark Slifstein, Judy Thompson, Xiaoyan Xu, Jill Harkavy-Friedman, Yael Beckerman, Elizabeth Raggi, Beatriz Alvarez, Roberto Gil, Anissa Abi-Dargham

NeuroImage, 2010

Imaging dopamine transmission in cannabis dependence.

Nina Urban, Mark Slifstein, Judy Thompson, Xiaoyan Xu, Felipe Castillo, Olga Medina, Najate Ojeil, Megan Haney, Anissa Abi-Dargham

NeuroImage, 2010

Amphetamine-induced striatal dopamine release in major depressive disorder.

Judy Thompson, Franklin R. Schneier, Mark Slifstein, Xiaoyan Xu, Lawrence S. Kegeles, Nina Urban, Ragy R. Girgis, Marc Laruelle, Anissa Abi-Dargham

NeuroImage, 2010

PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists.

Graham E. Searle, John D. Beaver, Laura E. Iavarone, Robert A. Comley, Massimo Bani, Andri C. Tziortzi, Mark Slifstein, Alan A. Wilson, Roger N. Gunn, Eugenii A. Rabiner, Marc Laruelle

NeuroImage, 2010

PET measurement of nicotine evoked dopamine release.

Khanum Ridler, Jean-Dominique Gallezot, Richard E. Carson, David Weinzimmer, Mark Slifstein, Roger N. Gunn, Marc Laruelle, Eugenii A. Rabiner

NeuroImage, 2010

Evaluation of the in vivo ED₅₀ for the PET Radioligand, [¹¹C]GSK-215083, in Papio anubis.

Christine A. Parker, Laurent Martarello, Eugenii A. Rabiner, Roger N. Gunn, Marc Laruelle, Mark Slifstein, Vincent J. Cunningham

NeuroImage, 2010

Reproducibility and sensitivity to pharmacological challenge of [11C]-ABP688 in non-human primate brain.

Nobumi Miyake, Mark Slifstein, Mette Skinbjerg, Xiaoyan Xu, Rawad Ayoub, Balu Easwaramoorthy, Sung-A. Bae, Elizabeth Hackett, John Castrillon, Lawrence S. Kegeles, Anissa Abi-Dargham

NeuroImage, 2010

Neurochemistry of obsessive-compulsive disorder: A combined PET and MRS study.

Lawrence S. Kegeles, H. Blair Simpson, Xiaoyan Xu, Xiangling Mao, Rena Staub, James Bender, Olga Medina, Mark Slifstein, Dikoma C. Shungu, Anissa Abi-Dargham

NeuroImage, 2010

In vivo binding of antipsychotics to D3 and D2 receptors: A PET study in baboons with [11C]-(+)-PHNO.

Ragy R. Girgis, Nobumi Miyake, Xiaoyan Xu, Balu Easwaramoorthy, John Castrillon, Roger N. Gunn, Eugenii A. Rabiner, Anissa Abi-Dargham, Mark Slifstein

NeuroImage, 2010

Effect of antipsychotic treatment on cortical D1 receptors.

Anissa Abi-Dargham, Xiaoyan Xu, Judy Thompson, Roberto Gil, Lawrence S. Kegeles, Nina Urban, Raj Narendran, Dah-Ren Hwang, Marc Laruelle, Mark Slifstein

NeuroImage, 2010

2001

A Reference Effect Approach for Power Analysis in fMRI.

Eric Zarahn, Mark Slifstein

NeuroImage, 2001